Biodesix Debt to Equity Ratio 2020-2024 | BDSX
Biodesix Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2024-09-30 | $0.08B | $0.03B | 2.69 |
2024-06-30 | $0.08B | $0.04B | 2.20 |
2024-03-31 | $0.09B | $-0.01B | -16.85 |
2023-12-31 | $0.10B | $0.01B | 20.64 |
2023-09-30 | $0.09B | $-0.00B | -61.02 |
2023-06-30 | $0.09B | $-0.01B | -12.10 |
2023-03-31 | $0.08B | $0.01B | 16.76 |
2022-12-31 | $0.07B | $0.02B | 3.51 |
2022-09-30 | $0.07B | $-0.00B | -22.77 |
2022-06-30 | $0.07B | $0.01B | 8.81 |
2022-03-31 | $0.05B | $0.01B | 6.92 |
2021-12-31 | $0.06B | $0.02B | 2.86 |
2021-09-30 | $0.07B | $0.02B | 4.61 |
2021-06-30 | $0.08B | $0.03B | 2.95 |
2021-03-31 | $0.08B | $0.04B | 2.17 |
2020-12-31 | $0.08B | $0.04B | 1.94 |
2020-09-30 | $0.30B | $-0.26B | -1.18 |
2020-06-30 | $0.00B | $0.00B | 0.00 |
2020-03-31 | $0.00B | $0.00B | 0.00 |
2019-12-31 | $0.00B | 0.00 | |
2019-09-30 | $0.00B | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.151B | $0.049B |
Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $92.839B | 12.14 |
Cencora (COR) | United States | $49.468B | 18.60 |
DiDi Global (DIDIY) | China | $22.650B | 0.00 |
Natera (NTRA) | United States | $22.209B | 0.00 |
ICON (ICLR) | Ireland | $16.344B | 14.56 |
Revvity (RVTY) | United States | $15.033B | 26.11 |
Avantor (AVTR) | United States | $14.626B | 21.93 |
BioMerieux (BMXMF) | France | $14.203B | 0.00 |
Viatris (VTRS) | United States | $13.523B | 4.17 |
CochLear (CHEOY) | Australia | $12.916B | 0.00 |
Solventum (SOLV) | United States | $12.870B | 0.00 |
Doximity (DOCS) | United States | $10.767B | 63.37 |
Medpace Holdings (MEDP) | United States | $10.662B | 30.04 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.135B | 0.00 |
HealthEquity (HQY) | United States | $9.429B | 47.30 |
Sonic Healthcare (SKHHY) | Australia | $8.657B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.266B | 15.97 |
Bausch + Lomb (BLCO) | Canada | $6.301B | 29.31 |
Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
BrightSpring Health Services (BTSG) | United States | $4.136B | 87.96 |
Organon (OGN) | United States | $4.079B | 4.11 |
Sotera Health (SHC) | United States | $3.875B | 20.73 |
Surgery Partners (SGRY) | United States | $3.273B | 37.32 |
Concentras Parent (CON) | United States | $2.998B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.937B | 0.00 |
Premier (PINC) | United States | $2.191B | 11.40 |
Ardent Health Partners (ARDT) | United States | $2.098B | 0.00 |
PACS (PACS) | United States | $2.080B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.079B | 0.00 |
Progyny (PGNY) | United States | $1.980B | 40.09 |
GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
Teladoc Health (TDOC) | United States | $1.782B | 0.00 |
Agilon Health (AGL) | United States | $1.413B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Pediatrix Medical (MD) | United States | $1.219B | 11.92 |
CareDx (CDNA) | United States | $1.210B | 0.00 |
Embecta (EMBC) | United States | $1.070B | 7.48 |
AMN Healthcare Services Inc (AMN) | United States | $1.036B | 7.02 |
Establishment Labs Holdings (ESTA) | $0.947B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.637B | 0.00 |
SBC Medicals (SBC) | United States | $0.518B | 0.00 |
InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
DocGo (DCGO) | United States | $0.490B | 18.46 |
QDM (QDMI) | Hong Kong, SAR China | $0.480B | 12.56 |
Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
Enhabit (EHAB) | United States | $0.422B | 36.52 |
COMPASS Pathways (CMPS) | United Kingdom | $0.280B | 0.00 |
MultiPlan (MPLN) | United States | $0.267B | 0.00 |
LifeMD (LFMD) | United States | $0.248B | 0.00 |
Nutex Health (NUTX) | United States | $0.243B | 0.00 |
Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
Beauty Health (SKIN) | United States | $0.205B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
So-Young (SY) | China | $0.105B | 17.83 |
Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
ModivCare (MODV) | United States | $0.066B | 3.57 |
Oncology Institute (TOI) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
OncoCyte (OCX) | United States | $0.034B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
KindlyMD (KDLY) | United States | $0.008B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |